• Aspergillus Antibody, IgE, Serum
  • Neurotrophic Receptor Tyrosine Kinase 3 (NTRK3) Gene Mutation Analysis (Translocation)
  • Methotrexate, Serum
  • ATP binding cassette subfamily G member 2 (ABCG2) Genotyping
  • SARS-CoV-2 (Coronavirus), Antigen Test
  • Biopsy, Bladder
  • Culture, Viral, Non-respiratory
  • Semen Analysis
  • Diphtheria Toxoid Antibody, IgG
  • Leukocyte Alkaline Phosphatase
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Turnaround Time
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...